Mark Massaro

Brandon Couillard

Mason Carrico

Tycho Peterson

Thomas DeBourcy

William Bonello

Yi Chen

Andrew Cooper

Eduardo Martinez

Noah Colby

Prashant Kota

Tom DeBourcy

- CareDx announced **new IVD products** and **IVDR certification** for its AlloSeq® Tx and QTYPE® products at the 2025 American Society of Histocompatibility & Immunogenetics Annual Meeting.  **[1217234_f3f3814a62b44030a299cb712424d4f7_0]** 
- Key product launches include **AlloSeq Tx11**, a next-generation HLA typing solution with enhanced Class II coverage and non-HLA markers, and **SCORE 7 Software** for QTYPE.  **[1217234_f3f3814a62b44030a299cb712424d4f7_0]** 
- The company also introduced a **novel HLA Typing Assay** in an Early Access Program and presented a poster on a **rapid ABO Genotyping Assay**.  **[1217234_f3f3814a62b44030a299cb712424d4f7_0]** 
- The **IVDR certification** for AlloSeq® Tx and QTYPE® ensures compliance with European Union regulations, reinforcing CareDx's position in transplant solutions.  **[1217234_f3f3814a62b44030a299cb712424d4f7_0]** **[1217234_f3f3814a62b44030a299cb712424d4f7_1]**

CareDx Announces New IVD Products and IVDR Certification

CareDx (CDNA)